TCTR20200901002已完成不适用
Therapeutic Drug Monitoring of Meropenem and Clinical Cure Assessment in Critically Ill Pediatric Patients: a Prospective Observational Study
Clinical pharmacokinetics and pharmacogenomics research unit0 个研究点目标入组 72 人开始时间: 2020年9月1日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 72
研究概览
简要总结
In progress
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 1 Months 至 18 Years（—）
- 性别
- All
入选标准
- •1. Pediatric patients ranged in age from 1 month to 18 years who admit into pediatric wards in King Chulalongkorn Memorial Hospital
- •2. Patients were received meropenem
- •3. Body weight more than 3 kilograms
- •4. CVC or A-line
排除标准
- •1. Patients were received valproic acid, probenecid, Patients were received valproic acid and probenecid
- •2. GFR is less than 60 ml/min/1.73 m2
- •3. Use or plan of ECMO and RRT
- •4. Penicillin allergy
研究者
相似试验
招募中
不适用
Therapeutic drug monitoring of Meropenem, Linezolide and Tigecyclin in liver failure. Quantification of liver function with Maximal Liver Function Capacity test (LiMAx-Test).K72.0Acute and subacute hepatic failureDRKS00008888Charité - Universitätsmedizin Berlin, Campus Virchow Klinikum. Klinik für Allgemein-, Visceral, und Transplantationschirurgie420
已完成
不适用
Meropenem and Piperacillin Plasma Concentrations During CRRTInfectionAntibioticRenal Replacement TherapyHemolysisSepsisNCT04203784Karolinska University Hospital135
尚未招募
不适用
Pharmacokinetics and Therapeutic Drug Monitoring of Intravenous Sulbactam in PediatricsPK parameters of sulbactam in pediatric patients with proven or suspected multidrug resistance A. baumannii infection receiving intravenous sulbactamSulbactam, TDM, pharmacokinetics, A. baumannnii, pediatricsTCTR20221114001Ratchadapisek Sompoch Research Fund62
已完成
3 期
Efficacy, Pharmacokinetics and Safety of Meropenem in Infants Below 90 Days With Clinical or Confirmed Late-onset SepsisSepsisNCT01551394PENTA Foundation272
已完成
4 期
Population Pharmacokinetics and Monte Carlo Dosing Simulations of Meropenem During the Early Phase of Severe Sepsis and Septic Shock in Critically Ill Patients in Intensive Care UnitsInitial Phase of Severe Sepsis and Septic ShockNCT02213796Sutep Jaruratanasirikul9